Vivo Capital » Investment News
63 FOLLOWERS
This section of the blog features articles on Healthcare Investment. Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies. Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development and commercial stage products. Since inception, the firm has approximately $5.8 billion in..
Vivo Capital » Investment News
3w ago
Categories
All News
Portfolio News
Vivo News
The post Verona Pharma’s Ohtuvayre™ (ensifentrine) Receives FDA Approval, Poised to Revolutionize the COPD Market” appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
3w ago
Categories
All News
Portfolio News
Vivo News
The post Ronovo Surgical Close $44M Series B financing to advance Carina™ Platform towards Commercialization and International Expansion appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
1M ago
Categories
All News
Portfolio News
Vivo News
The post Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
2M ago
Categories
All News
Portfolio News
Vivo News
The post Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
2M ago
Categories
All News
Portfolio News
Vivo News
The post Soleno Therapeutics Received Breakthrough Therapy Designation from U.S.FDA For DCCR (Diazoxide Choline) Extended-Release Tables in Prader-Willi (PWS) appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Sinovac completes Investment in Synermore Biologics, Entering New Field of Innovative Antibody Drugs
Vivo Capital » Investment News
3M ago
Categories
All News
Portfolio News
Vivo News
The post Sinovac completes Investment in Synermore Biologics, Entering New Field of Innovative Antibody Drugs appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
3M ago
Categories
All News
Portfolio News
Vivo News
The post Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion in Cash, Leveraging Povetacicept for IgA Nephropathy and Autoimmune Diseases appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
5M ago
Categories
All News
Portfolio News
Vivo News
The post VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
5M ago
Categories
All News
Portfolio News
Vivo News
The post Evaheart Launches EVA-Pulsar™, Second Generation Destination Therapy Left Ventricular Assist Device (LVAD) Treating Heart Failure Patients appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
5M ago
Categories
All News
Portfolio News
Vivo News
The post Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more